Cite
Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS.
MLA
Broglie, Larisa, et al. “Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS.” Biology of Blood & Marrow Transplantation, vol. 21, no. 2, Feb. 2015, pp. S210–11. EBSCOhost, https://doi.org/10.1016/j.bbmt.2014.11.321.
APA
Broglie, L., Chaudhury, S., Helenowski, I., Jennings, L., Schafernak, K., Duerst, R. E., Tse, W. T., Kletzel, M., & Schneiderman, J. (2015). Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS. Biology of Blood & Marrow Transplantation, 21(2), S210–S211. https://doi.org/10.1016/j.bbmt.2014.11.321
Chicago
Broglie, Larisa, Sonali Chaudhury, Irene Helenowski, Larry Jennings, Kristian Schafernak, Reggie E. Duerst, William T. Tse, Morris Kletzel, and Jennifer Schneiderman. 2015. “Predicting Relapse Post-Hematopoietic Stem Cell Transplant for Pediatric AML and MDS.” Biology of Blood & Marrow Transplantation 21 (2): S210–11. doi:10.1016/j.bbmt.2014.11.321.